Amanote Research
Register
Sign In
In Vitro Pharmacological Characterization of a Novel TRPA1 Antagonist and Proof of Mechanism in a Human Dental Pulp Model
Journal of Pain Research
- New Zealand
doi 10.2147/jpr.s37567
Full Text
Open PDF
Abstract
Available in
full text
Categories
Anesthesiology
Pain Medicine
Date
January 1, 2013
Authors
Eva Nyman
Publisher
Informa UK Limited
Related search
In Vitro Pharmacological Properties of KRH-594, a Novel Angiotensin II Type 1 Receptor Antagonist.
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
In Vitro and in Silico Characterization of Lemborexant (E2006), a Novel Dual Orexin Receptor Antagonist
Journal of Pharmacology and Experimental Therapeutics
Molecular Medicine
Pharmacology
A Pharmacological Model of TRPA1-Mediated Nociception in Zebrafish for Therapeutic Discovery
Journal of Purdue Undergraduate Research
Expression and Influence of BMP‑4 in Human Dental Pulp Cells Cultured In�vitro
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
A Human TRPA1-specific Pain Model
Journal of Neuroscience
Neuroscience
Identification and in Vitro Pharmacological Characterization of a Novel and Selective Α7 Nicotinic Acetylcholine Receptor Agonist, Br-Iq17b
Acta Pharmacologica Sinica
Medicine
Pharmacology
In Vitro Histomorphometric Comparison of Dental Pulp Tissue in Different Teeth
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
Pharmacological Profile of VP-343, a Novel Selective Vasopressin V2 Receptor Antagonist, in Rats.
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
A TRPA1 Antagonist Reverts Oxaliplatin-Induced Neuropathic Pain
Scientific Reports
Multidisciplinary
